A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy

Nat Clin Pract Urol. 2006 Dec;3(12):675-9. doi: 10.1038/ncpuro0655.

Abstract

Background: A 61-year-old woman with a substantial history of smoking presented with gross hematuria. Cystoscopic evaluation revealed a large bladder tumor.

Investigations: Cystoscopic evaluation, histological examination, crosssectional imaging.

Diagnosis: High-grade muscle-invasive transitional cell carcinoma (clinical stage T2N0M0, later confirmed as pathologic stage T3aN0M0).

Management: Transurethral resection of the bladder tumor, clinical trialbased neoadjuvant treatment with paclitaxel, carboplatin and gemcitabine, and radical cystectomy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Carcinoma, Transitional Cell / diagnosis
  • Carcinoma, Transitional Cell / therapy*
  • Female
  • Humans
  • Middle Aged
  • Muscle Neoplasms / diagnosis
  • Muscle Neoplasms / secondary
  • Muscle Neoplasms / therapy*
  • Neoadjuvant Therapy / methods*
  • Neoplasm Invasiveness / diagnosis
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / therapy*